Search

everythinglearnresearchcommunity

for

Search:↓

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

People with alopecia areata may also have allergic rhinitis and should be checked for respiratory allergies.

Treatment type and patch size affect hair regrowth patterns in alopecia areata.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Obesity and bariatric surgery can cause hair thinning and temporary hair loss due to nutritional deficiencies and stress.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Some children may develop hair loss after having COVID-19.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Baricitinib is effective for severe alopecia areata but has some side effects.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

Manipulating cell cleanup processes could help treat hair loss.

JAK inhibitors show promise as a future treatment for hair loss.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Latanoprost is more effective than minoxidil for treating alopecia areata.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.

Ginger extract helps hair growth and reduces the need for prednisolone in alopecia areata patients.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.